Jun Huang
Clinical trials sponsored by Jun Huang, explained in plain language.
-
Radiation and immunotherapy join forces against Hard-to-Treat liver metastases
Disease control Recruiting nowThis study tests whether combining a precise form of radiation (SBRT) with an immunotherapy drug (PD-1 monoclonal antibody) can help people whose colorectal cancer has spread to the liver and cannot be removed surgically. The trial enrolls adults aged 18 to 75 with a specific typ…
Phase: PHASE3 • Sponsor: Jun Huang • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for tough colon cancer: drug cocktail boosts surgery success
Disease control Recruiting nowThis study tests whether adding two drugs (bevacizumab and a PD-1 inhibitor) to standard chemotherapy before surgery can improve outcomes for people with a common, hard-to-treat type of colorectal cancer. About 166 adults with locally advanced pMMR/MSS colorectal cancer will be r…
Phase: PHASE3 • Sponsor: Jun Huang • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC